{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:38:55Z","timestamp":1793320735638,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":130,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Japan Agency for Medical Research and Development","award":["JP22bm0804034"],"award-info":[{"award-number":["JP22bm0804034"]}],"id":[{"id":"https:\/\/ror.org\/004rtk039","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Japan Agency for Medical Research and Development","award":["JP23bm1423014"],"award-info":[{"award-number":["JP23bm1423014"]}],"id":[{"id":"https:\/\/ror.org\/004rtk039","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Japan Agency for Medical Research and Development","award":["JP23bm1323001"],"award-info":[{"award-number":["JP23bm1323001"]}],"id":[{"id":"https:\/\/ror.org\/004rtk039","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Japan Agency for Medical Research and Development","award":["JP24wm0625501"],"award-info":[{"award-number":["JP24wm0625501"]}],"id":[{"id":"https:\/\/ror.org\/004rtk039","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Japan Agency for Medical Research and Development","award":["JP24bm1123047"],"award-info":[{"award-number":["JP24bm1123047"]}],"id":[{"id":"https:\/\/ror.org\/004rtk039","id-type":"ROR","asserted-by":"crossref"}]},{"name":"JSPS KAKENHI","award":["23K06827"],"award-info":[{"award-number":["23K06827"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of motor neurons. Accurate and accessible blood-based diagnostics for neurodegenerative diseases, including ALS, are being progressively required. Although blood cell gene expression profiles have potential clinical utility for distinguishing ALS, robust transcriptomic biomarkers for supportive diagnosis have not yet been established. Here, we analyzed publicly available peripheral blood mononuclear cell (PBMC) transcriptomic data from ALS patients using Maximum Mean Discrepancy, a kernel-based method that captures nonlinear distributional differences in a reproducing kernel Hilbert space and enables the extraction of informative gene combinations while minimizing multicollinearity, a common issue in multiple regression models. Using this approach, we identified a nonlinear three-gene combination\u2014PRKAR1A, QPCT, and TMEM71\u2014that distinguished ALS from healthy controls with an area under the curve (AUC) of 0.83 in a public PBMC dataset. This achievement was confirmed in laboratory PBMC samples with an AUC of 0.85, supporting the robustness of the identified gene signature in independent samples. Furthermore, these genes also enabled ALS classification in induced pluripotent stem cell-derived motor neurons with an AUC of 0.79. Knockdown of PRKAR1A, QPCT, or TMEM71 in motor neurons increased the TDP-43 expression levels, and PRKAR1A knockdown induced the mislocalization of TDP-43, accompanied by phosphorylation, suggesting a potential link to ALS-related pathophysiology. These findings suggest that nonlinear gene combinations may provide a useful strategy for identifying blood-based biomarkers and offer insights into ALS pathogenesis. This nonlinear, data-driven analytical framework enabled the transition from unbiased gene discovery to the identification of pathophysiology-associated molecules by in vitro functional validation.<\/jats:p>","DOI":"10.1093\/biomethods\/bpag023","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:48:49Z","timestamp":1778240929000},"source":"Crossref","is-referenced-by-count":1,"title":["Nonlinear combinatorial analysis of blood transcriptomes identifies PRKAR1A as a regulator of TDP-43 pathophysiology in amyotrophic lateral sclerosis"],"prefix":"10.1093","volume":"11","author":[{"given":"Keiko","family":"Imamura","sequence":"first","affiliation":[{"name":"Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP) , Kyoto, 606-8507,","place":["Japan"]},{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University , Kyoto, 606-8507,","place":["Japan"]},{"name":"iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC) , Kyoto, 606-8507,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nagahashi","sequence":"additional","affiliation":[{"name":"Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP) , Kyoto, 606-8507,","place":["Japan"]},{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University , Kyoto, 606-8507,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Okusa","sequence":"additional","affiliation":[{"name":"Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP) , Kyoto, 606-8507,","place":["Japan"]},{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University , Kyoto, 606-8507,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP) , Kyoto, 606-8507,","place":["Japan"]},{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University , Kyoto, 606-8507,","place":["Japan"]},{"name":"Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University , Kyoto, 606-8507,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3048-9041","authenticated-orcid":false,"given":"Yuishin","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokushima University Graduate School of Biomedical Sciences , Tokushima, 770-8503,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naonori","family":"Ueda","sequence":"additional","affiliation":[{"name":"Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP) , Kyoto, 606-8507,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kawahara","sequence":"additional","affiliation":[{"name":"Dynamical Systems Learning Team, RIKEN Center for Advanced Intelligence Project (AIP) , Osaka, 565-0871,","place":["Japan"]},{"name":"Graduate School of Information Science and Technology, The University of Osaka , Osaka, 565-0871,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4736-9537","authenticated-orcid":false,"given":"Haruhisa","family":"Inoue","sequence":"additional","affiliation":[{"name":"Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP) , Kyoto, 606-8507,","place":["Japan"]},{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University , Kyoto, 606-8507,","place":["Japan"]},{"name":"iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC) , Kyoto, 606-8507,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"2026102103463421900_bpag023-B1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrneurol.2011.153","article-title":"Clinical diagnosis and management of amyotrophic lateral sclerosis","volume":"7","author":"Hardiman","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"2026102103463421900_bpag023-B2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-020-00406-3","article-title":"Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers","volume":"15","author":"Zucchi","year":"2020","journal-title":"Mol Neurodegener"},{"key":"2026102103463421900_bpag023-B3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ana.26860","article-title":"Biomarker qualification for neurofilament light chain in amyotrophic lateral sclerosis: Theory and Practice","volume":"95","author":"Benatar","year":"2024","journal-title":"Ann Neurol"},{"key":"2026102103463421900_bpag023-B4","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.3390\/ijms23052580","article-title":"Biomarkers in human peripheral blood mononuclear cells: The state of the art in amyotrophic lateral sclerosis","volume":"23","author":"Pansarasa","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026102103463421900_bpag023-B5","doi-asserted-by":"publisher","first-page":"106823","DOI":"10.1016\/j.nbd.2025.106823","article-title":"Whole transcriptome analysis of unmutated sporadic ALS patients\u2019 peripheral blood reveals phenotype-specific gene expression signature","volume":"206","author":"Dragoni","year":"2025","journal-title":"Neurobiol Dis"},{"key":"2026102103463421900_bpag023-B6","doi-asserted-by":"publisher","first-page":"e49-57","DOI":"10.1093\/bioinformatics\/btl242","article-title":"Integrating structured biological data by Kernel Maximum Mean Discrepancy","volume":"22","author":"Borgwardt","year":"2006","journal-title":"Bioinformatics"},{"key":"2026102103463421900_bpag023-B7","doi-asserted-by":"publisher","first-page":"615747","DOI":"10.3389\/fcell.2021.615747","article-title":"An accurate tool for uncovering cancer subtypes by fast kernel learning method to integrate multiple profile data","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026102103463421900_bpag023-B8","doi-asserted-by":"publisher","first-page":"101953","DOI":"10.1016\/j.media.2020.101953","article-title":"Incomplete multi-modal representation learning for Alzheimer\u2019s disease diagnosis","volume":"69","author":"Liu","year":"2021","journal-title":"Med Image Anal"},{"key":"2026102103463421900_bpag023-B9","doi-asserted-by":"publisher","first-page":"e0198874","DOI":"10.1371\/journal.pone.0198874","article-title":"Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study","volume":"13","author":"van Rheenen","year":"2018","journal-title":"PLoS One"},{"key":"2026102103463421900_bpag023-B10","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2026102103463421900_bpag023-B11","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The SVA package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"2026102103463421900_bpag023-B12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/humu.22157","article-title":"ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics","volume":"33","author":"Abel","year":"2012","journal-title":"Hum Mutat"},{"key":"2026102103463421900_bpag023-B13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/stem.1293","article-title":"An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells","volume":"31","author":"Okita","year":"2013","journal-title":"Stem Cells"},{"key":"2026102103463421900_bpag023-B14","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/ana.26047","article-title":"Prediction model of amyotrophic lateral sclerosis by deep learning with patient induced pluripotent stem cells","volume":"89","author":"Imamura","year":"2021","journal-title":"Ann Neurol"},{"key":"2026102103463421900_bpag023-B15","doi-asserted-by":"publisher","first-page":"eaaf3962","DOI":"10.1126\/scitranslmed.aaf3962","article-title":"The Src\/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis","volume":"9","author":"Imamura","year":"2017","journal-title":"Sci Transl Med"},{"key":"2026102103463421900_bpag023-B16","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1212\/wnl.0000000000004516","article-title":"Analysis of blood-based gene expression in idiopathic Parkinson disease","volume":"89","author":"Shamir","year":"2017","journal-title":"Neurology"},{"key":"2026102103463421900_bpag023-B17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12967-019-1909-0","article-title":"ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia","volume":"17","author":"Swindell","year":"2019","journal-title":"J Transl Med"},{"key":"2026102103463421900_bpag023-B18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/1389450120666190806153206","article-title":"Amyloid beta hypothesis in Alzheimer\u2019s disease: Major culprits and recent therapeutic strategies","volume":"21","author":"Vijayan","year":"2020","journal-title":"Curr Drug Targets"},{"key":"2026102103463421900_bpag023-B19","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1210\/en.2004-0900","article-title":"Minireview: PRKAR1A: Normal and abnormal functions","volume":"145","author":"Bossis","year":"2004","journal-title":"Endocrinology"},{"key":"2026102103463421900_bpag023-B20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1046\/j.1471-4159.2003.01669.x","article-title":"Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over-expressing mice","volume":"85","author":"Hu","year":"2003","journal-title":"J Neurochem"},{"key":"2026102103463421900_bpag023-B21","doi-asserted-by":"publisher","first-page":"e20201105","DOI":"10.1084\/jem.20191734","article-title":"Synaptic restoration by cAMP\/PKA drives activity-dependent neuroprotection to motoneurons in ALS","volume":"217","author":"B\u0105czyk","year":"2020","journal-title":"J Exp Med"},{"key":"2026102103463421900_bpag023-B22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3233\/jad-120517","article-title":"Increased glutaminyl cyclase expression in peripheral blood of Alzheimer\u2019s disease patients","volume":"34","author":"Valenti","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"2026102103463421900_bpag023-B23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nchembio.1790","article-title":"siRNA screen identifies QPCT as a druggable target for Huntington\u2019s disease","volume":"11","author":"Jimenez-Sanchez","year":"2015","journal-title":"Nat Chem Biol"},{"key":"2026102103463421900_bpag023-B24","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1007\/s12035-015-9541-3","article-title":"Common polymorphisms within QPCT gene are associated with the susceptibility of schizophrenia in a Han Chinese population","volume":"53","author":"Zhang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"2026102103463421900_bpag023-B25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/cns.13137","article-title":"Molecular and clinical characterization of TMEM71 expression at the transcriptional level in glioma","volume":"25","author":"Wang","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"2026102103463421900_bpag023-B26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13041-020-00607-3","article-title":"CCR2 is localized in microglia and neurons, as well as infiltrating monocytes, in the lumbar spinal cord of ALS mice","volume":"13","author":"Komiya","year":"2020","journal-title":"Mol Brain"},{"key":"2026102103463421900_bpag023-B27","doi-asserted-by":"publisher","first-page":"146366","DOI":"10.1016\/j.gene.2022.146366","article-title":"Blood-based gene-expression biomarkers identification for the non-invasive diagnosis of Parkinson\u2019s disease using two-layer hybrid feature selection","volume":"823","author":"Augustine","year":"2022","journal-title":"Gene"},{"key":"2026102103463421900_bpag023-B28","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/jamaneurol.2022.3282","article-title":"Amyotrophic lateral sclerosis clinical trials and interpretation of functional end points and fluid biomarkers: A review","volume":"79","author":"Shefner","year":"2022","journal-title":"JAMA Neurol"},{"key":"2026102103463421900_bpag023-B29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/s1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: Towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol"}],"container-title":["Biology Methods and Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomethods\/advance-article-pdf\/doi\/10.1093\/biomethods\/bpag023\/68268763\/bpag023.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/11\/1\/bpag023\/68268763\/bpag023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/11\/1\/bpag023\/68268763\/bpag023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:46:38Z","timestamp":1792568798000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomethods\/article\/doi\/10.1093\/biomethods\/bpag023\/8675976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/biomethods\/bpag023","relation":{},"ISSN":["2396-8923"],"issn-type":[{"value":"2396-8923","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"bpag023"}}